Sign in

CIK 0001785530

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Werewolf Therapeutics, Inc.

Sign in to watch
Ticker
HOWL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
823523180
Phone
+1 617-952-0555
Business address
303 WYMAN STREET, SUITE 300, WALTHAM, MA, 02451
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2023-01-03 HICKLIN DANIEL J Grant or award · Stock Option (right to buy) +295,500 295,500
2023-01-03 Lubman Ellen Chief Business Officer Grant or award · Stock Option (right to buy) +86,200 86,200
2023-01-03 Seidel-Dugan Cynthia Chief Scientific Officer Grant or award · Stock Option (right to buy) +115,900 115,900
2023-01-03 Karunatilake Chulani Chief Technology Officer Grant or award · Stock Option (right to buy) +103,600 103,600
2023-01-03 Trost Timothy W. Chief Financial Officer Grant or award · Stock Option (right to buy) +102,800 102,800
2023-01-03 Leonard Reid Chief Operating Officer Grant or award · Stock Option (right to buy) +93,600 93,600
2023-01-03 Isaacs Randi Chief Medical Officer Grant or award · Stock Option (right to buy) +103,300 103,300
2022-06-01 RA CAPITAL MANAGEMENT, L.P. Director Grant or award · Stock Option (Right to Buy) +11,600 11,600
2022-06-01 EVNIN LUKE Director Grant or award · Stock Option (right to buy) +11,600 11,600
2022-06-01 DiRocco Derek Director Grant or award · Stock Option (right to buy) +11,600 11,600
2022-06-01 Morrison Briggs Director Grant or award · Stock Option (right to buy) +11,600 11,600
2022-06-01 Karunatilake Chulani Chief Technology Officer Grant or award · Stock Option (right to buy) +136,000 136,000
2022-06-01 Lazarus Alon Director Grant or award · Stock Option (right to buy) +11,600 11,600
2022-06-01 Sherman Michael A. Director Grant or award · Stock Option (right to buy) +11,600 11,600
2022-06-01 Chatterjee Meeta Director Grant or award · Stock Option (right to buy) +7,733 7,733
2022-01-12 Seidel-Dugan Cynthia Chief Scientific Officer Exercise or conversion +24,199 $1.56 $38K 149,356
2022-01-12 Seidel-Dugan Cynthia Chief Scientific Officer Exercise or conversion +15,532 $4.77 $74K 164,888
2022-01-12 Seidel-Dugan Cynthia Chief Scientific Officer Exercise or conversion · Stock Option (right to buy) −24,199 36,937
2022-01-12 Seidel-Dugan Cynthia Chief Scientific Officer Exercise or conversion · Stock Option (right to buy) −15,532 83,631
2022-01-06 Isaacs Randi Chief Medical Officer Grant or award · Stock Option (right to buy) +79,516 79,516

Page 12 of 17 · 335 trades